Article Contents ::
- 1 Details Descriptions About :: Cervical Cancer
- 2 The third most common cancer of the female reproductive system, cervical cancer is classified as either microinvasive or invasive. Precancerous dysplasia, also called cervical intraepithelial carcinoma or cervical carcinoma in situ, is more frequent than invasive cancer and occurs more often in younger women.
- 3 Causes for Cervical Cancer
- 4 Pathophysiology Cervical Cancer
- 5 Signs and symptoms Cervical Cancer
- 6 Diagnostic Lab Test results
- 7 Treatment for Cervical Cancer
- 8 Disclaimer ::
- 9 The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.
Details Descriptions About :: Cervical Cancer
The third most common cancer of the female reproductive system, cervical cancer is classified as either microinvasive or invasive. Precancerous dysplasia, also called cervical intraepithelial carcinoma or cervical carcinoma in situ, is more frequent than invasive cancer and occurs more often in younger women.
Causes for Cervical Cancer
Causes Cause unknown Predisposing factors include Frequent intercourse at a young age (under age 16) Multiple sexual partners Multiple pregnancies Sexually transmitted diseases (particularly genital human papillomavirus [HPV]) Smoking
Pathophysiology Cervical Cancer
Pathophysiology Preinvasive disease ranges from mild cervical dysplasia, in which the lower third of the epithelium contains abnormal cells, to carcinoma in situ, in which the full thickness of epithelium contains abnormally proliferating cells. Other names for carcinoma in situ include cervical intraepithelial neoplasia and squamous intraepithelial lesion. Preinvasive disease detected early and properly treated is curable in 75% to 90% of cases. If preinvasive disease remains untreated (and depending on the form in which it appears), it may progress to invasive cervical cancer. In invasive carcinoma, cancer cells penetrate the basement membrane and can spread directly to contiguous pelvic structures or disseminate to distant sites by lymphatic routes. In almost all cases of cervical cancer (95%), the histologic type is squamous cell carcinoma, which varies from well-differentiated cells to highly anaplastic spindle cells. Only 5% are adenocarcinomas. Age Alert Usually, invasive carcinoma occurs in women between ages 30 and 50; rarely, in those under age 20.
Signs and symptoms Cervical Cancer
Signs and symptoms Preinvasive disease Often produces no symptoms or other clinically apparent changes Early invasive cervical cancer Abnormal vaginal bleeding Persistent vaginal discharge Postcoital pain and bleeding Advanced disease Pelvic pain Vaginal leakage of urine and stool from a fistula Anorexia, weight loss, and anemia
Diagnostic Lab Test results
Diagnostic test results Papanicolaou (Pap) test screens for abnormal cells. Colposcopy shows the source of the abnormal cells seen on the Pap test. Cone biopsy is performed if endocervical curettage is positive. Vira-Pap test permits examination of the specimen’s deoxyribonucleic acid structure to detect HPV. Lymphangiography and cystography detect metastasis. Organ and bone scans show metastasis.
Treatment for Cervical Cancer
Treatment Preinvasive lesions Loop electrosurgical excision procedure Cryosurgery Laser destruction Conization (with frequent Pap smear follow-up) Hysterectomy Invasive carcinoma Radical hysterectomy Radiation therapy (internal, external, or both) Chemotherapy Combination of the above procedures Clinical Tip: Pap smear findings Normal Large, surface-type squamous cells Small, pyknotic nuclei Mild dysplasia Mild increase in nuclear:cytoplasmic ratio Hyperchromasia Abnormal chromatin pattern Severe dysplasia, carcinoma in situ Basal type cells Very high nuclear:cytoplasmic ratio Marked hyperchromasia Abnormal chromatin Invasive carcinoma Marked pleomorphism Irregular nuclei Clumped chromatin Prominent nucleoli